Literature DB >> 34278082

Infrainguinal bypass under triple nerve block in patients with severely compromised left ventricular ejection fraction and chronic limb-threatening ischemia.

Muzafar Mamatkulov1, Nikolai Naumov1, Pavel Kurianov2, Alexey Yaroslavsky1, Alexey Sergeev3, Anastasia Voronova1.   

Abstract

A severely compromised left ventricular ejection fraction (LVEF) is a major limitation for lower extremity bypass reconstruction both under general anesthesia or neuraxial anesthesia (NA). A series of eight infrainguinal bypass procedures were performed under peripheral nerve block in five patients (three males and two females; median age, 67 years) with chronic limb-threatening ischemia and a preoperative LVEF of 35% or less (median, 27%; range, 20%-35%). There were no conversions to neuraxial anesthesia/general anesthesia or early postoperative complications. This study showed that open infrainguinal reconstructions can be performed safely under peripheral nerve blockade in this vulnerable category of patients.
© 2021 The Authors.

Entities:  

Keywords:  Bypass; Chronic limb-threatening ischemia; Left ventricular ejection fraction; Peripheral nerve block; Systolic dysfunction

Year:  2021        PMID: 34278082      PMCID: PMC8263527          DOI: 10.1016/j.jvscit.2021.05.004

Source DB:  PubMed          Journal:  J Vasc Surg Cases Innov Tech        ISSN: 2468-4287


Bypass surgery remains one of the cornerstones of revascularization strategy for chronic limb-threatening ischemia (CLTI), particularly in patients with long femoropopliteal occlusions. However, congestive heart failure (CHF) owing to a compromised left ventricular ejection fraction (LVEF) is a major limitation for open noncardiac surgery owing to high perioperative risk.2, 3, 4, 5, 6, 7, 8, 9, 10 Avoiding general anesthesia (GA) in favor of neuraxial anesthesia (NA) or regional analgesia has been suggested as one of the ways to decrease the perioperative risks in this vulnerable patient category.11, 12, 13, 14 GA implies the use of substances that might compromise central hemodynamics., NA does not affect the heart directly, but tends to cause acute hypotension owing to peripheral vasodilation.16, 17, 18 Peripheral nerve block (PNB) of the lower limb is thought to be bereft of these pitfalls.,, However, high-quality evidence on open infrainguinal reconstructions under regional nerve block have been very sparse. This retrospective single-arm clinical study describes the results of several infrainguinal bypass procedures performed in patients with CLTI with severely compromised LVEF under regional nerve blockade.

Methods

This single-center single-arm retrospective study was conducted in accordance with the Declaration of Helsinki and approved by the institutional ethics board. All patients provided informed consent for the procedure and publication of their clinical data. The study included patients with preoperative LVEF of greater than 35% according to echocardiography who had CLTI owing to peripheral arterial disease and underwent open lower limb revascularization under regional nerve blockade. Demographics and clinical characteristics, surgical risk, operative details, course of anesthesia, early outcomes (30-day mortality, perioperative complications, hospital stay) and long-term variables (overall survival, limb salvage, bypass primary patency, freedom from target lesion revascularization and healing rate at 6 months) were evaluated. All patients underwent basic clinical evaluation by a vascular specialist, appropriate laboratory tests, preoperative echocardiography, and vascular imaging. Surgical risk was defined for each patient using the risk scoring system developed by the American College of Surgeons' National Surgical Quality Improvement Program. The Weibull parametric regression model was used to predict survival at 6 months, 1 year, and 2 years. Patients were premedicated with 5 mg of intramuscular diazepam and 1 mg of intramuscular atropine. The regional nerve block was performed by an appropriately trained surgeon from the vascular team who injected a local anesthetic solution around the sciatic nerve, femoral nerve, and two branches (anterior and posterior) of the obturator nerve under ultrasound guidance with 20.0 to 40.0 mL of a mixture of 0.2% ropivacaine (2 mg/kg body weight) and 4.0 mL of 0.4% dexamethasone, added to 40.0 mL with normal saline. No nerve stimulator was used. When necessary, the skin below the inguinal ligament was anesthetized with additional injections of 1.0% lidocaine. A technically successful nerve block was confirmed by pin-prick test before proceeding to intervention and by direct contact to the patient within the course of surgical procedure. Another way to control the course of anesthesia was intraoperative monitoring, including noninvasive blood pressure measurement, electrocardiography, and pulse oximetry. All bypass procedures were performed with an autologous vein and according to a standard of care approach. All patients underwent duplex ultrasound examination the day after the intervention to assess early patency of the bypass. After discharge, patients were followed up by telephone at 3-month intervals. Primary patency of vein conduit was assessed at 6 months with duplex ultrasound examination. Anesthesia was considered adequate if the patient experienced no limb pain during the intervention and no significant changes in vital signs were detected.

Results

A total of five patients (three males and two females) underwent eight infrainguinal bypass reconstructions under PNB (Table I). The median patient age was 67 years (range, 57-72 years), the median LVEF was 27% (range, 20%-35%). The calculated perioperative mortality risk ranged from 6.7% to 8.0%, the predicted 2-year survival was 63.0% to 92.0%. Distribution of comorbidities was typical for CLTI with hypertension and coronary artery disease, with CHF being evident in most patients. None of the patients had acutely decompensated CHF. Preoperative angiography revealed extremely long femoropopliteal occlusions (>30 cm) involving both superficial the femoral and popliteal arteries in five of the eight patients (62.5%).
Table I

Baseline demographic and clinical characteristics of patients

Patient No., age, and sexCLTI signsEstimated ACS NSQIP perioperative death risk, %Estimated survival, %
LVEF, %BMIComorbiditiesMedicationsWIfI stageCTA/DSA data
6 months1 year2 years
Patient 1: 57 years old, maleRest painTissue loss7.784.075.063.023.018.2HTNCADCHFHistory of MIDiureticsStatinsOACACEI4CFA stenosisSFA CTOPA CTO
Patient 2: 66 years old, maleRest painTissue loss8.093.089.083.020.025.3HTNCADCHFAF (chronic)DiureticsStatinsClopidogrelOACBBACEI4PA CTO
Patient 3: 67 years old, maleaRest pain7.897.095.092.035.035.9HTNCADCHFAF (chronic)HypoalbuminemiaDiureticsStatinsOACBB1SFA CTOPA CTO
Patient 4: 71 years old, femaleRest painTissue loss6.793.089.083.033.028.7HTNCADCHFDMDiureticsStatinsClopidogrelBB4SFA CTOPA CTO
Patient 5: 72 years old, femalebRest painTissue loss7.492.088.081.027.021.3HTNCADCHFHistory of MIAF (chronic)DiureticsStatinsClopidogrelOACBBACEICCB4Both sides:SFA CTOATA CTOPTA CTO

ACEI, Angiotensin-converting enzyme inhibitor; ACS NSQIP, American College of Surgeons' National Surgical Quality Improvement Program; AF, atrial fibrillation; ATA, anterior tibial artery; BB, beta-blocker; BMI, body mass index; CAD, coronary artery disease; CCB, calcium channel blocker; CFA, common femoral artery; CHF, congestive heart failure; CLTI, chronic limb-threatening ischemia; CTA, computed tomography angiography; CTO, chronic total occlusion; DM, diabetes mellitus; DSA, digital subtraction angiography; HTN, hypertension; LVEF, left ventricular ejection fraction; MI, myocardial infarction; OAC, oral anticoagulants; PA, popliteal artery; PTA, posterior tibial artery; SFA, superficial femoral artery; WIfI, Society of Vascular Surgery Wound, Ischemia, foot Infection grading system.

This patient had three consecutive infrainguinal bypass reconstructions performed under peripheral nerve block on the same limb within a 6-month interval.

This patient had two bypass infrainguinal reconstructions performed on different limbs within a 2-month interval.

Baseline demographic and clinical characteristics of patients ACEI, Angiotensin-converting enzyme inhibitor; ACS NSQIP, American College of Surgeons' National Surgical Quality Improvement Program; AF, atrial fibrillation; ATA, anterior tibial artery; BB, beta-blocker; BMI, body mass index; CAD, coronary artery disease; CCB, calcium channel blocker; CFA, common femoral artery; CHF, congestive heart failure; CLTI, chronic limb-threatening ischemia; CTA, computed tomography angiography; CTO, chronic total occlusion; DM, diabetes mellitus; DSA, digital subtraction angiography; HTN, hypertension; LVEF, left ventricular ejection fraction; MI, myocardial infarction; OAC, oral anticoagulants; PA, popliteal artery; PTA, posterior tibial artery; SFA, superficial femoral artery; WIfI, Society of Vascular Surgery Wound, Ischemia, foot Infection grading system. This patient had three consecutive infrainguinal bypass reconstructions performed under peripheral nerve block on the same limb within a 6-month interval. This patient had two bypass infrainguinal reconstructions performed on different limbs within a 2-month interval. The anesthesia was adequate with complete pain control in all patients, no significant limb motion issues, and no conversions to NA or GA. No patient developed a significant change in heart rate or blood pressure or required inotropic support during or after the intervention. The median duration of the surgery was 275 minutes (range, 150-360 minutes) (Table II). The median postoperative hospital stay was 4.5 days (range, 3-11 days). There were no perioperative deaths, and none of the patients developed bypass failure or underwent major amputation within 30 days postoperatively. The 6-month primary patency, limb salvage, amputation-free survival, freedom from target lesion revascularization, and foot healing rates were all 87.5%. The overall survival rate was 100%.
Table II

Procedural details and 30-day outcomes

Patient No., age, and sexProcedure time, minutesProximal anastomosis siteDistal anastomosis siteConduit typeHospital stay, days30-Day outcomes
Patient 1: 57 years old, male300External iliac artery (terminal portion)Posterior tibial arterySpliced vein graft (GSV + LSV)5Uneventful recovery
Patient 2: 66 years old, male280Superficial femoral arteryPeroneal arterySingle-segment vein conduit (GSV)5Uneventful recovery
Patient 3: 67 years old, male150Common femoral arteryPosterior tibial arterySingle-segment vein conduit (GSV)11Uneventful recovery
285Common femoral arteryPosterior tibial arterySingle-segment vein conduit (GSV)a6Uneventful recovery
270Common femoral arteryPosterior tibial arterySpliced vein graft (GSV + LSV)4Uneventful recovery
Patient 4: 71 years old, female360Common femoral arteryPeroneal arterySingle-segment vein conduit (GSV)4Uneventful recovery
Patient 5: 72 years old, female210Common femoral arteryPopliteal arterySingle-segment vein conduit (GSV)3Uneventful recovery
270Common femoral arteryPopliteal arterySingle-segment vein conduit (GSV)3Uneventful recovery

GSV, Greater saphenous vein; LSV, lesser saphenous vein.

The GSV was harvested from the contralateral limb.

Procedural details and 30-day outcomes GSV, Greater saphenous vein; LSV, lesser saphenous vein. The GSV was harvested from the contralateral limb.

Discussion

HF remains highly prevalent in the elderly population,, with nearly one-half of all HF cases being due to impaired LV systolic function. In turn, a compromised LVEF remains a the key factor in predicting perioperative mortality in noncardiac interventions,2, 3, 4, 5, 6, 7, 8, 9, 10 particularly those performed for CLTI owing to peripheral arterial disease.24, 25, 26 Issues associated with GA in HF with a reduced LVEF include maintaining forward flow to prevent coronary ischemia, pulmonary hypertension, and end-organ dysfunction, as well as the need to promote inotropy without inducing or worsening ischemia., Therefore, patients with extremely low LVEF may be deemed unfit for open surgery under GA. NA (spinal or epidural) carries a risk of hypotension during or immediately after the intervention,, which increases perioperative mortality and is a particular issue in diabetic patients owing to cardiovascular autonomic neuropathy. Large comparative studies of GA vs NA in patients undergoing lower extremity bypass did not stratify patients according to LVEF.,, In the only published comparative study of PNB vs GA in infrainguinal bypass procedures by Kikuchi et al, the median LVEF in patients treated under nerve blockade was nearly normal (50.3%) and, again, no stratification was performed based on this factor. Based on the study by Rohde et al, we used 35% or lower as a threshold for defining a severely compromised LVEF as measured by two-dimensional echocardiography. The procedure time in our study ranged from 150 to 300 minutes, which was substantially longer than the duration of, for example, minor foot amputations performed under regional anasthesia. Still, the PNB allowed completion of the intervention successfully. We observed no significant issues related to voluntary or involuntary limb motions during surgery, probably owing to obturator nerve block, which was avoided by other authors. Despite significant National Surgical Quality Improvement Program-calculated mortality, there were no early deaths in our study. The predicted 2-year survival was well above 50%. Importantly, all of our patients had very long and totally occluded femoropopliteal lesions; thus, no endovascular approach could be reasonably considered as a first-line strategy.

Conclusions

Overall, this study showed that even the most time consuming and complicated open infrainguinal reconstructions can be done safely under PNB in select patients with CLTI with severely compromised left ventricular systolic function. Larger comparative studies are needed to better define the category of patients who may benefit from this type of anesthesia.
  28 in total

1.  Association of Left Ventricular Ejection Fraction and Symptoms With Mortality After Elective Noncardiac Surgery Among Patients With Heart Failure.

Authors:  Benjamin J Lerman; Rita A Popat; Themistocles L Assimes; Paul A Heidenreich; Sherry M Wren
Journal:  JAMA       Date:  2019-02-12       Impact factor: 56.272

2.  Editor's Choice - Regional Versus General Anaesthesia in Peripheral Vascular Surgery: a Propensity Score Matched Nationwide Cohort Study of 17 359 Procedures in Denmark.

Authors:  Jannie Bisgaard; Christian Torp-Pedersen; Bodil S Rasmussen; Kim C Houlind; Signe J Riddersholm
Journal:  Eur J Vasc Endovasc Surg       Date:  2021-01-07       Impact factor: 7.069

Review 3.  Epidemiology of diastolic heart failure.

Authors:  Theophilius E Owan; Margaret M Redfield
Journal:  Prog Cardiovasc Dis       Date:  2005 Mar-Apr       Impact factor: 8.194

4.  Mortality and readmission of patients with heart failure, atrial fibrillation, or coronary artery disease undergoing noncardiac surgery: an analysis of 38 047 patients.

Authors:  Sean van Diepen; Jeffrey A Bakal; Finlay A McAlister; Justin A Ezekowitz
Journal:  Circulation       Date:  2011-06-27       Impact factor: 29.690

5.  Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.

Authors:  Michael S Conte; Andrew W Bradbury; Philippe Kolh; John V White; Florian Dick; Robert Fitridge; Joseph L Mills; Jean-Baptiste Ricco; Kalkunte R Suresh; M Hassan Murad; Victor Aboyans; Murat Aksoy; Vlad-Adrian Alexandrescu; David Armstrong; Nobuyoshi Azuma; Jill Belch; Michel Bergoeing; Martin Bjorck; Nabil Chakfé; Stephen Cheng; Joseph Dawson; Eike S Debus; Andrew Dueck; Susan Duval; Hans H Eckstein; Roberto Ferraresi; Raghvinder Gambhir; Mauro Gargiulo; Patrick Geraghty; Steve Goode; Bruce Gray; Wei Guo; Prem C Gupta; Robert Hinchliffe; Prasad Jetty; Kimihiro Komori; Lawrence Lavery; Wei Liang; Robert Lookstein; Matthew Menard; Sanjay Misra; Tetsuro Miyata; Greg Moneta; Jose A Munoa Prado; Alberto Munoz; Juan E Paolini; Manesh Patel; Frank Pomposelli; Richard Powell; Peter Robless; Lee Rogers; Andres Schanzer; Peter Schneider; Spence Taylor; Melina V De Ceniga; Martin Veller; Frank Vermassen; Jinsong Wang; Shenming Wang
Journal:  Eur J Vasc Endovasc Surg       Date:  2019-06-08       Impact factor: 7.069

6.  Effectiveness and Safety of Ultrasound Guided Lower Extremity Nerve Blockade in Infragenicular Bypass Grafting for High Risk Patients With Chronic Limb Threatening Ischaemia.

Authors:  Shinsuke Kikuchi; Takuya Yamaguchi; Keisuke Miyake; Daiki Uchida; Atsuhiro Koya; Takafumi Iida; Atsushi Kurosawa; Tomoki Sasakawa; Takayuki Kunisawa; Nobuyoshi Azuma
Journal:  Eur J Vasc Endovasc Surg       Date:  2019-07-01       Impact factor: 7.069

7.  Effects of anesthesia versus regional nerve block on major leg amputation mortality rate.

Authors:  Roy Lin; Anil Hingorani; Natalie Marks; Enrico Ascher; Robert Jimenez; Thom McIntyre; Theresa Jacob
Journal:  Vascular       Date:  2013-03-22       Impact factor: 1.285

8.  Cardiac outcome after peripheral vascular surgery. Comparison of general and regional anesthesia.

Authors:  R H Bode; K P Lewis; S W Zarich; E T Pierce; M Roberts; G J Kowalchuk; P R Satwicz; G W Gibbons; J A Hunter; C C Espanola
Journal:  Anesthesiology       Date:  1996-01       Impact factor: 7.892

9.  Predictive scoring model of mortality after surgical or endovascular revascularization in patients with critical limb ischemia.

Authors:  Tatsuya Shiraki; Osamu Iida; Mitsuyoshi Takahara; Shin Okamoto; Ikurou Kitano; Yoshihiko Tsuji; Hiroto Terashi; Masaaki Uematsu
Journal:  J Vasc Surg       Date:  2014-04-14       Impact factor: 4.268

10.  Prevention of hypotension induced by combined spinal epidural anesthesia using continuous infusion of vasopressin: A randomized trial.

Authors:  Chetna Shamshery; Ashish Kannaujia; Rajashree Madabushi; Dinesh Singh; Divya Srivastava; Shobhana Jafa
Journal:  Anesth Essays Res       Date:  2016 Sep-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.